Gulf Coast Canna Meds

Gulf Coast Canna Meds

Closed: Apr. 2018

About this raise

Who Should Be Interested:
Do you live in Florida and use medical marijuana? Do you want to have strains cultivated specifically for your ailments and created by professionals with deep industry experience? If this sounds like you, then Gulf Coast Canna Meds, Inc. could be the investment you’ve been waiting for. Their goal is to a community leader for Florida’s medical marijuana population, offering unique strains, personalized treatments, and safe products.

The Company:
Gulf Coast Canna Meds, Inc. (GCCM) plans to be the leader in Florida’s medical marijuana industry. Their business will include cultivation, extraction, processing, manufacturing, distribution, and dispensing operations, with a focus on creating unique strains with distinct cannabinoid profiles that are safe, pure, and precisely formulated. GCCM plans to offer marijuana concentrates, vaporizer cartridges, topicals, and other infused products. They will sell their products at their own dispensary locations, as well as to other MMTC’s in Florida. Their dispensaries will be able to fully accommodate people with disabilities and the elderly, as well as provide skilled and knowledgeable dispensary technicians. GCCM has partnered with Constance Therapeutics, the world leader in medical marijuana, and they are also working with Canna Advisors, who are known for the high success rate in licences approval.

The Bottom Line:
Florida is expected to become the second largest market for medicinal marijuana after California, and GCCM isn’t just talking the medical marijuana talk -- they’re walking the walk. They want to become a leader in the Florida industry, and given the fact that they’ve already made a name for themselves through their active effort to legalize marijuana in Florida, as well through their membership of Florida For Care, it seems like they are well on their way to doing so.

Expand

Investment Overview

Not Funded: $1,074,025

Deal Terms

Total Commitments

Platform
Fundanna
Start Date
01/30/2018
Close Date
04/30/2018
Min. Goal
$20,000
Max Goal
$1,070,000
Min. Investment

$100

Security Type

SAFE

Company Stage

Early Stage

SEC Filing Type

RegCF    Open SEC Filing

Valuation Cap

$8,100,000

Discount

0%

Company & Team

Company

Year Founded
2016
Industry
Alcohol, Tobacco, & Recreational Drugs
Tech Sector
Distribution Model
B2B2C
Margin
Capital Intensity
Location
St Petersburgh, Florida
Company Website
Visit Website

Team

Employees
1

Financials

Financials are not currently available for this company. This may occur if the company is still Testing the Waters, is a Regulation D offering, or if the financials are still under review and being confirmed by our team. For Reg CF and Reg A+ raises, please check back later.

Upgrade to gain access

Pay Monthly
Annually (2 months free)

Edge

$12.50 /month
billed annually
Free portfolio tracking, data-driven ratings, AI analysis and reports
Plan Includes:
Everything in Free, plus
Company specific Kingscrowd ratings and analyst reports
Deal explorer and side-by-side comparison
Startup exit and failure tracking
Startup market filters and historical industry data
Advanced company search ( with ratings)
Get Edge Annual
Already a member? Log in here.

Company Funding & Growth

Funding history

Close Date Platform Valuation Total Raised Security Type Status Reg Type
04/30/2018 Fundanna $8,100,000 $1,074,025 SAFE Not Funded RegCF
Create a free account today to gain access to Kingscrowd analytics.
Founders: enhance your startup's credibility on Kingscrowd. Create an account to claim this raise page.
Add to portfolio
Gulf Coast Canna Meds on Fundanna
Platform: Fundanna
Security Type: SAFE
Valuation: $8,100,000

Follow company

Follow Gulf Coast Canna Meds on Fundanna

Buy Gulf Coast Canna Meds's Deal Report

Warning: according to the close date for this deal, Gulf Coast Canna Meds may no longer be accepting investments.

Gulf Coast Canna Meds Deal Report

Get Kingscrowd's comprehensive report on Gulf Coast Canna Meds including:

  • How our proprietary algorithm rates their current capital raise (1-5 stars)
  • Detailed price, market, team, differentiators, performance, and risk ratings
  • Whether Gulf Coast Canna Meds is undervalued or overvalued
  • Scores on the founding team and key personnel's background and expertise

Buy the Gulf Coast Canna Meds deal report for only $10!

Email address:
Looking to buy more than one deal report? Get unlimited reports by upgrading to Edge